Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Subscription Receivable [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Total
Beginning balance, value at Dec. 31, 2023	$ 1,827	$ 100,841,416	$ (1,817,640)	$ (96,499,518)	$ (569,749)	$ 1,956,336
Beginning balance, shares at Dec. 31, 2023	182,625
Stock-based compensation		351,488				351,488
Foreign exchange translation loss					17,906	17,906
Net loss				(2,456,915)		(2,456,915)
Common Stock sold under the Equity Distribution Agreement, net of offering costs of $583,713	$ 1,112	1,807,677				1,808,789
Common stock sold under the Equity Distribution Agreement, net of offering cost, shares	111,200
Issuance of direct offering shares	$ 152	322,301				322,453
Issuance of direct offering shares, shares	15,246
Exercise of Inducement Warrants for Common Stock	$ 1,303	2,675,677				2,676,980
Exercise of Inducement Warrants for common stock, shares	130,267
Proceeds from the subscription receivable related to the issuance of Inducement Warrants, net of offering costs of $12,821		(12,821)	280,500			267,679
Proceeds from the subscription receivable related to the exercise of warrants and preferred investment options and issuance of Common Stock in abeyance	$ 469	(469)	1,537,140			1,537,140
Proceeds from the subscription receivable related to the exercise of warrants and preferred investment options and issuance of common stock in abeyance, shares	46,934
Ending balance, value at Mar. 31, 2024	$ 4,863	105,985,269		(98,956,433)	(551,843)	6,481,856
Ending balance, shares at Mar. 31, 2024	486,272
Beginning balance, value at Dec. 31, 2023	$ 1,827	100,841,416	(1,817,640)	(96,499,518)	(569,749)	1,956,336
Beginning balance, shares at Dec. 31, 2023	182,625
Foreign exchange translation loss						3,254
Net loss						(4,336,309)
Ending balance, value at Jun. 30, 2024	$ 5,254	106,803,332		(100,835,827)	(566,495)	5,406,264
Ending balance, shares at Jun. 30, 2024	525,245
Beginning balance, value at Mar. 31, 2024	$ 4,863	105,985,269		(98,956,433)	(551,843)	6,481,856
Beginning balance, shares at Mar. 31, 2024	486,272
Issuance of common shares for vested RSU	$ 1	(1)
Issuance of common shares for vested RSU, shares	105
Stock-based compensation		369,614				369,614
Foreign exchange translation loss					(14,652)	(14,652)
Net loss				(1,879,394)		(1,879,394)
Issuance of direct offering shares	$ 306	448,534				448,840
Issuance of direct offering shares, shares	30,534
Common Stock sold under the Purchase Agreement, net of offering costs of $82,850	$ 84	(84)
Common Stock sold under the Purchase Agreement, net of offering costs, shares	8,334
Ending balance, value at Jun. 30, 2024	$ 5,254	106,803,332		(100,835,827)	(566,495)	5,406,264
Ending balance, shares at Jun. 30, 2024	525,245
Beginning balance, value at Dec. 31, 2024	$ 6,780	108,255,049		(106,074,505)	(594,517)	1,592,807
Beginning balance, shares at Dec. 31, 2024	678,002
Issuance of Common Stock and Series A and B and prefunded warrants for cash, net of offering costs of $755,487	$ 12,293	4,232,174				4,244,467
Issuance of common stock and Series A and B and prefunded warrants for cash, net of offering costs, shares	1,229,330
Issuance of common shares for vested RSU	$ 146	(146)
Issuance of common shares for vested RSU, shares	14,586
Issuance of common shares for exercise of warrants	$ 4,623	70,421				75,044
Issuance of common shares for exercise of warrants, shares	462,336
Issuance of round up shares	$ 874	(874)
Issuance of round up shares, shares	87,402
Stock-based compensation		193,848				193,848
Foreign exchange translation loss					(3,487)	(3,487)
Net loss				(2,184,966)		(2,184,966)
Ending balance, value at Mar. 31, 2025	$ 24,716	112,750,472		(108,259,471)	(598,004)	3,917,713
Ending balance, shares at Mar. 31, 2025	2,471,656
Beginning balance, value at Dec. 31, 2024	$ 6,780	108,255,049		(106,074,505)	(594,517)	1,592,807
Beginning balance, shares at Dec. 31, 2024	678,002
Foreign exchange translation loss						20,986
Net loss						(4,704,147)
Ending balance, value at Jun. 30, 2025	$ 30,260	113,506,692		(110,778,652)	(573,531)	2,184,769
Ending balance, shares at Jun. 30, 2025	3,026,028
Beginning balance, value at Mar. 31, 2025	$ 24,716	112,750,472		(108,259,471)	(598,004)	3,917,713
Beginning balance, shares at Mar. 31, 2025	2,471,656
Stock-based compensation		206,260				206,260
Foreign exchange translation loss					24,473	24,473
Net loss				(2,519,181)		(2,519,181)
Issuance of common shares for cash pursuant to ATM Agreement, net of offering costs of $179,714	$ 5,544	549,960				555,504
Issuance of common shares for cash pursuant to ATM Agreement, net of offering costs, shares	554,372
Ending balance, value at Jun. 30, 2025	$ 30,260	$ 113,506,692		$ (110,778,652)	$ (573,531)	$ 2,184,769
Ending balance, shares at Jun. 30, 2025	3,026,028